🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to compare the disease-free survival betw...
Status
Recruiting
Location
Arkansas Urology
Start Date
2024-04-18
Trial ID
NCT06319820
Treatments Being Tested
Bladder cancers are associated with genetic mutations that are present in t...
Status
Terminated
Location
xCures Virtual Site
Start Date
2021-11-21
Trial ID
NCT05052372
Treatments Being Tested
Erdafitinib (ERDA) alone or in combination with cetrelimab (CET) as neoadju...
Status
Recruiting
Location
CLCC Jean Perrin
Start Date
2023-03-07
Trial ID
NCT06511648
Treatments Being Tested
This phase II trial compares the effect of erdafitinib alone to using the c...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-12
Trial ID
NCT05564416
The purpose of this study is to evaluate the relative bioavailability of JN...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02231489
Treatments Being Tested
This is a single participant study of erdafitinib for the treatment of a pa...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2022-05-30
Trial ID
NCT06328491
Treatments Being Tested
The primary purpose of the study is to characterize the single dose pharmac...
Status
Terminated
Location
CRS Clinical Research Services Kiel GmbH
Start Date
2018-12-06
Trial ID
NCT03587363
Treatments Being Tested
The primary purpose of this study is to identify the recommended Phase 2 do...
Status
Completed
Location
National Cancer Center Hospital
Start Date
2018-08-31
Trial ID
NCT03547037
Treatments Being Tested
The purpose of the study is to determine the tolerability of erdafitinib in...
Status
Active Not Recruiting
Location
St Marianna University Hospital
Start Date
2023-03-03
Trial ID
NCT05567185
Treatments Being Tested
The purpose of the study in Part 1 (dose escalation) and in Part 2 (dose ex...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham - The Kirklin Clinic
Start Date
2022-04-11
Trial ID
NCT05316155
Treatments Being Tested